Asia-Pacific
The merger of two IP boutiques could prompt others to follow suit and challenge Australia’s externally funded firms
A defeat for AstraZeneca and Open Innovation Network's 20th anniversary were also among the top talking points this week
Leaders at the newly merged firm Jones Maxwell Smith & Davis reveal their plan to take on bigger firms while attracting more clients and talent
Jinwon Chun discusses the need for vigilance, his love for iced coffee, and preparing for INTA
Sponsored
Sponsored
-
Sponsored by Remfry & SagarCyril Abrol of Remfry & Sagar reports that India is not confining itself to small steps as the country aims to take a giant leap in the global space race -
Sponsored by FirstLaw PCHyoun-Ja Park and Minji Ryan Kim of FirstLaw PC analyse two significant developments as South Korea attempts to strengthen its protection of trade secrets and proprietary information involving industrial and national core technologies
-
Sponsored by Anand and AnandTusha Malhotra and Tanvi Bhatnagar of Anand and Anand say technological advances such as those in AI are presenting new challenges in protecting the personality rights of celebrities in India and necessitate a delicate balancing act
-
Sponsored by Shiga International Patent OfficeMasato Iida of Shiga International Patent Office explains what types of bio inventions are deemed eligible for patent protection in Japan and draws comparisons with US practice
-
Sponsored by Shiga International Patent OfficeThe Japan Patent Office has published additional case examples designed to clarify the patentability of AI-related technology. Fumio Takahashi of Shiga International Patent Office explains the new guidance
-
Sponsored by Wanhuida Intellectual PropertyA ruling on the inventiveness of a compound patent for a prostate cancer therapeutic could help create uniform jurisprudence regarding the examination of pharmaceutical patents, says Guan Yue of Wanhuida Intellectual Property
